Company Description
ABBIOSCI is a US-based biotechnology company found in 2010.
ABBIOSCI main focus is to make suitable, workable and applicable format antibodies and develop antibody-based products by using established technical platform, Multiple-Format-Antibody (MFAbs). There are four available formats, polyclonal antibody (pAb), monoclonal antibody (mAb), recombinant antibody (rAb) and antibody engineering (Ab-Eng). Characterization, combination, conversion and engineering of each format of antibody are applied to customer�s project from case to case. New generation of antibody to novel and difficulty targets and their engineering are also provided.